If you are not able to view this e-mail properly, please click here to view it online
World Pharma Today Maqazine
World Pharma Today Linkedin Page World Pharma Today Facebook Page World Pharma Today Twitter Page DOWNLOAD
MEDIAPACK 2018
Click here to subscribe to our Magazine
Alliance Life Sciences
Latest Press Releases
Elsevier collaborates with Beijing University of Chinese Medicine

Elsevier collaborates with Beijing University of Chinese Medicine to enable deeper research into traditional Chinese medicine

As global interest in traditional and alternative medicine grows, Elsevier, the global information analytics business specializing in science and health, announced that it is working with BUCM...

READ MORE

Saneca Pharma renews Pharmascience agreement following successful quality audit

Contract development and manufacturing organisation Saneca Pharma has renewed an agreement with Pharmascience Inc, one of Canada's largest pharmaceutical companies...

READ MORE

Biogen, AbbVie draw Multiple Sclerosis Drug On Inflammation Reports

RBC analyst Brian Abrahams said the decision will have zero material impact on Biogen as Zinbryta was expected to bring in about $400 million in 2027 revenue for the company, or less than 3% of total sales.Zinbryta is not one of Biogen's core MS drugs...

READ MORE
Latest News
AbbVie increases 9.7% since earning reports

AbbVie increases 9.7% since earning reports: Can it persist?

A month has gone by since the last earnings report for AbbVie Inc. ABBV . Shares have added about 9.7% in that time frame, outperforming the market. Will the recent positive trend continue leading up to its next earnings release...

READ MORE

Advanced Laboratory Management System Now Available on a Global Scale

Laboratory scientists across the globe can now benefit from a software system that helps them manage the entire lab, designed to support process adherence, data integrity and complete...

READ MORE

Haverford Trust Co. elevated its position in shares of Eli Lilly and Co by 16.3%

Haverford Trust Co. lifted its position in shares of Eli Lilly and Co by 16.3% during the fourth quarter, according to the company in its most recent filing with the SEC.The institutional investor owned 6,105 shares of the company's stock after buying an additional 854 shares...

READ MORE

For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
or
call to: + 91 88268 49084

If you like to receive our latest Media Pack 2018 / Editorial Calender please click here

For the latest visit: www.worldpharmatoday.com

World Pharma Today